Feed Top Reports Pricing

⌘K

16:17:03·1261d

SECFiling

SEC Form 10-Q filed by Cortexyme Inc.

CRTX· Cortexyme Inc.

Health Care

Full content unavailable. See the original source below.

Original source

Companies

CRTX
Cortexyme Inc.
Health Care

Recent analyst ratings

Mar 9UpdateHC Wainwright & Co.$15.00
Jan 28UpdateCanaccord Genuity$12.00
Jan 28UpdateCanaccord Genuity-
Jan 27UpdateJMP Securities-
Oct 27UpdateB of A Securities-
Oct 27UpdateBofA Securities$15.00

Related

SEC1224d
Cortexyme Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
INSIDER1233d
SEC Form 4: Monohon Ted covered exercise/tax liability with 1,640 shares, decreasing direct ownership by 5% to 29,311 units to cover taxes
SEC1301d
Cortexyme Inc. filed SEC Form 8-K: Leadership Update
INSIDER1323d
SEC Form 4: Monohon Ted covered exercise/tax liability with 1,520 shares, decreasing direct ownership by 5% to 30,951 units to cover taxes
SEC1361d
Cortexyme Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
NEWS1365d
Stocks That Hit 52-Week Lows On Thursday
NEWS1366d
Recap of Wednesday's Biotech Catalysts - End of The Day Summary
NEWS1366d
Stocks That Hit 52-Week Lows On Wednesday

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds

Top lists

Trending By market cap Active companies Analyst upgrades Insider purchases FDA approvals SEC filings Sectors Market reports

Company

About Pricing Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022